Bortezomib with lenalidomide and dexamethasone versus lenalidomide and dexamethasone alone in patients with newly diagnosed myeloma without intent for immediate autologous stem-cell transplant (SWOG S0777): a randomised, open-label, phase 3 trial

Publication | Open Access

DOI Full Paper Access

868

Citations

References

2016

Year

Brian G.M. Durie, Antje Hoering, Muneer H. Abidi, S. Vincent Rajkumar, Joshua Epstein, Stephen P. Kahanic, Mohan C. Thakuri, Frederic J. Reu, Christopher M. Reynolds, Rachael Sexton,

The Lancet

Hematological MalignancyDexamethasone Versus LenalidomideOncologyMarrow TransplantationTransplantationHematologyMyeloid NeoplasiaRadiation OncologyMedicineCell TransplantationSwog S0777Health Sciences